Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$242,647
+$132,866 QoQ
Shares Held
25,759
+91.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#129
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Jun 30, 2026CallValue
$1,884
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,187,680 across 427 Biotechnology names. NVAX ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in NVAX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,647 | 25,759 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $1,884 | 200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $109,781 | 13,487 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $104,782 | 15,593 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,919,525 | 1,144,121 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,786,671 | 1,077,250 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $94,871 | 14,801 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $171,764 | 21,364 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $370,080 | 29,302 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $299,913 | 23,690 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $299,089 | 62,572 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $207,339 | 43,196 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $187,210 | 25,858 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $147,572 | 19,862 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $103,463 | 14,930 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $289,842 | 28,195 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $725,031 | 39,837 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,541,935 | 88,313 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $10,126,799 | 137,499 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,383,050 | 93,542 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,481,014 | 69,852 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,158,199 | 43,136 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,928,954 | 10,639 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $796,848 | 7,146 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,460,154 | 31,935 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $595,368 | 7,143 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $235,748 | 17,360 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||